Caris Life Sciences, Inc.

$26.50
(as of Jun 30, 1:56 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Ticker Information for Caris Life Sciences, Inc.

Stock Price
$26.50
Ticker Symbol
CAI
Exchange
NASDAQ

Industry Information for Caris Life Sciences, Inc.

Sector
Healthcare
Industry
Biotechnology

Company Description for Caris Life Sciences, Inc.

Website
https://www.carislifesciences.com
Country
USA
Full Time Employees
1,769

Caris Life Sciences, Inc., an artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally. It develops and commercializes solutions to transform healthcare using molecular information, and machine learning algorithms. The company's molecular profiling services portfolio includes MI Profile, a tissue-based molecular profiling solution; and Caris Assure, a blood-based molecular profiling solution for cancer treatment. It also offers pharma research and development services comprising laboratory delivery, strategic data, and research services to biopharmaceutical customers. The company was founded in 2008 and is headquartered in Irving, Texas.

Fundamentals for Caris Life Sciences, Inc.

Market Capitalization
$7,939,539,968
EBITDA
$-184,595,008
Dividends per Share
P/E Ratio
Forward P/E Ratio
0
Earnings per Share
$-1.25
Earnings per Share Estimate Next Year
Profit Margin
-60.43%
Shares Outstanding
283,555,008
Percent Owned by Insiders
48.16%
Percent Owned by Institutions
16.19%
52-Week High
52-Week Low

Technical Indicators for Caris Life Sciences, Inc.

50-Day Moving Average
200-Day Moving Average
RSI
0
ATR
0

Analyst Ratings for Caris Life Sciences, Inc.

Strong Buy
Buy
Hold
Sell
Strong Sell

News About Caris Life Sciences, Inc.

Jun 18, 2025, 8:03 PM EST
Cathie Wood’s ARK ETFs have made their latest round of daily trades for Wednesday, June 18th, 2025, with BWX Technologies Inc (NYSE:BWXT) and Veracyte Inc (NASDAQ:VCYT) topping the buy list, while Adaptive Biotechnologies Corp (NASDAQ:ADPT) and UiPath Inc (NYSE:PATH) were the most notable sales. See more.
Jun 18, 2025, 1:18 PM EST
[IPO and stock growth graph] See more.
Jun 18, 2025, 12:34 PM EST
Investing.com -- Caris Life Sciences shares started trading at $27 per share on Wednesday, marking a 29% increase from its initial public offering (IPO) price of $21 per share. See more.
Jun 18, 2025, 6:56 AM EST
[IPO and stock growth graph] See more.